Keywords: Alzheimer's Disease, Alzheimer's Disease, beta-amyloidAlzheimer’s disease (AD) is an age-associated neurodegenerative disease that is reaching epidemic proportions as a result of the aging of the world’s population. It is likely that the most effective treatment for AD will need to be administrated before cognitive symptoms occur, necessitating a biomarker for the early stages of AD. Novel high-resolution MRI technologies with the capability to characterize the individual beta-amyloid plaque through the whole brain is highly desirable.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords